Seeking Alpha

QualityStocks'  Instablog

Send Message
QualityStocks ( assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Threshold Pharmaceuticals, Inc. (THLD) Names Dr. Tillman Pearce As Chief Medical Officer 0 comments
    Feb 17, 2012 5:49 PM | about stocks: THLD
    Threshold Pharmaceuticals, a biotechnology company, announced today that it has appointed Tillman Pearce, M.D., as its chief medical officer. Dr. Pearce will oversee development of the company's TH-302, a clinical stage hypoxia-targeted cancer therapeutic currently being evaluated in a variety of cancers. TH-302 is presently undergoing a phase 3 trial in soft tissue sarcoma patients and a phase 2b trial in pancreatic cancer patients.

    Dr. Pearce has expertise in oncology drug development - both from the perspectives of large pharmaceutical companies and smaller entrepreneurial biotech companies. His almost two decades of international drug development experience will be valuable to Threshold as the company builds its new partnership with Merck KGaA.

    Dr. Pearce's professional history includes serving as director of oncology clinical research for Sandoz/Novartis, medical director at Sanofi-Synthelabo's Oncology Business Unit, and founder and director of PDL BioPharma France. Dr. Pearce most recently served as chief medical officer of KaloBios Pharmaceuticals.

    Threshold Pharmaceuticals focuses on discovering and developing drugs that target tumor hypoxia, a low oxygen condition found in the microenvironments of most solid tumors and the bone marrows of some hematologic malignancies. This approach offers wide-ranging potential for treating a variety of cancers. By selectively targeting tumor cells, the company is building a pipeline of promising drugs that will more effectively treat cancers with less toxicity to healthy tissues.

    For further information about the company, visit

    Please see disclaimer on the QualityStocks website:

    Stocks: THLD
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.